These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2023703)

  • 1. Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
    Lopez M; Carpano S; Di Lauro L; Vici P; Conti EM
    Oncology; 1991; 48(3):230-3. PubMed ID: 2023703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
    Borden EC; Amato DA; Rosenbaum C; Enterline HT; Shiraki MJ; Creech RH; Lerner HJ; Carbone PP
    J Clin Oncol; 1987 Jun; 5(6):840-50. PubMed ID: 3585441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study.
    Chevallier B; Leyvraz S; Olivier JP; Fargeot P; Facchini T; Vo Van ML
    Cancer Invest; 1993; 11(2):135-9. PubMed ID: 8462014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.
    Jelić S; Kovcin V; Milanović N; Babović N; Kreacić M; Ristović Z; Vlajić M; Filipović-Ljesković I
    Eur J Cancer; 1997 Feb; 33(2):220-5. PubMed ID: 9135492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.
    Bokemeyer C; Harstrick A; Schmoll HJ; Köhne-Wömpner CH; Schöffski P; Poliwoda H
    Ann Oncol; 1992 Jun; 3(6):487-8. PubMed ID: 1498067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
    Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
    Baker LH; Frank J; Fine G; Balcerzak SP; Stephens RL; Stuckey WJ; Rivkin S; Saiki J; Ward JH
    J Clin Oncol; 1987 Jun; 5(6):851-61. PubMed ID: 3295129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
    García-Del-Muro X; López-Pousa A; Maurel J; Martín J; Martínez-Trufero J; Casado A; Gómez-España A; Fra J; Cruz J; Poveda A; Meana A; Pericay C; Cubedo R; Rubió J; De Juan A; Laínez N; Carrasco JA; de Andrés R; Buesa JM;
    J Clin Oncol; 2011 Jun; 29(18):2528-33. PubMed ID: 21606430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Pinedo HM; Bramwell VH; Mouridsen HT; Somers R; Vendrik CP; Santoro A; Buesa J; Wagener T; van Oosterom AT; van Unnik JA
    Cancer; 1984 May; 53(9):1825-32. PubMed ID: 6367947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A combination chemotherapy with adriamycin, cyclophosphamide and DTIC (ACD) for advanced adult soft part sarcoma].
    Ikeda K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Usui N; Nakada H; Adachi K; Okada Y
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):235-9. PubMed ID: 6696459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group.
    Buesa JM; Mouridsen HT; van Oosterom AT; Verweij J; Wagener T; Steward W; Poveda A; Vestlev PM; Thomas D; Sylvester R
    Ann Oncol; 1991 Apr; 2(4):307-9. PubMed ID: 1868027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of epirubicin in advanced soft tissue sarcoma.
    Chevallier B; Montcuquet P; Fachini T; Nguyen Bui B; Kerbrat P; Bastit P; Vo Van ML
    Bull Cancer; 1990; 77(10):991-5. PubMed ID: 2249019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
    Harstrick A; Bokemeyer C; Schmoll HJ; Köhne-Wömpner CH; Knipp H; Schöffski P; Anagnou J; Wipperman B; Neumann S; Poliwoda H
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S217-21. PubMed ID: 8453702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.
    Casali P; Pastorino U; Zucchinelli P; Devizzi L; Azzarelli A; Quagliuolo V; Bignami P; Santoro A; Bonadonna G
    Ann Oncol; 1992 Apr; 3 Suppl 2():S125-6. PubMed ID: 1622854
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II evaluation of doxorubicin, ifosfamide, and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. A pilot study.
    González-Manzano R; Vieitez JM; Tangco E; Fernandez de Alava E; Herranz P; Garcia-Foncillas J
    Am J Clin Oncol; 1993 Aug; 16(4):332-7. PubMed ID: 8328412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas.
    Saiki JH; Baker LH; Rivkin SE; Shahbender S; Fletcher WS; Athens JW; Balcerzak SP; Bonnet JD
    Cancer; 1986 Nov; 58(10):2196-7. PubMed ID: 3756766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
    Elias A; Ryan L; Sulkes A; Collins J; Aisner J; Antman KH
    J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.
    Jain KK; Casper ES; Geller NL; Hakes TB; Kaufman RJ; Currie V; Schwartz W; Cassidy C; Petroni GR; Young CW
    J Clin Oncol; 1985 Jun; 3(6):818-26. PubMed ID: 3859587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
    Venturini M; Michelotti A; Del Mastro L; Gallo L; Carnino F; Garrone O; Tibaldi C; Molea N; Bellina RC; Pronzato P; Cyrus P; Vinke J; Testore F; Guelfi M; Lionetto R; Bruzzi P; Conte PF; Rosso R
    J Clin Oncol; 1996 Dec; 14(12):3112-20. PubMed ID: 8955656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of advanced soft-tissue sarcomas.
    Antman KH; Elias AD
    Semin Surg Oncol; 1988; 4(1):53-8. PubMed ID: 3281212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.